EdgarLookup

QWEST CORP — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that QWEST CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-27.9%
Profit Margin
Net income ÷ revenue
-8.4%
Return on Assets
Net income ÷ assets
-13.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.75B Feb 20, 2026
FY2025 Dec 31, 2024 $5.51B Feb 20, 2026
FY2025 Dec 31, 2023 $5.92B Feb 20, 2026
FY2024 Dec 31, 2022 $6.45B Feb 20, 2025
FY2023 Dec 31, 2021 $6.95B Feb 22, 2024
FY2022 Dec 31, 2020 $7.31B Feb 23, 2023
FY2019 Dec 31, 2019 $2.01B Mar 5, 2020
FY2019 Sep 30, 2019 $2.04B Mar 5, 2020
FY2019 Jun 30, 2019 $2.05B Mar 5, 2020
FY2019 Mar 31, 2019 $2.06B Mar 5, 2020

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.49B Feb 20, 2026
FY2025 Dec 31, 2024 $5.22B Feb 20, 2026
FY2025 Dec 31, 2023 $5.60B Feb 20, 2026
FY2024 Dec 31, 2022 $6.08B Feb 20, 2025
FY2023 Dec 31, 2021 $6.47B Feb 22, 2024
FY2022 Dec 31, 2020 $6.83B Feb 23, 2023
FY2021 Dec 31, 2019 $7.56B Feb 24, 2022
FY2020 Dec 31, 2018 $7.86B Mar 3, 2021

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2016 Dec 31, 2016 $6.25B Mar 2, 2017
FY2016 Dec 31, 2015 $6.56B Mar 2, 2017
FY2016 Dec 31, 2014 $6.68B Mar 2, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($1.33B) Feb 20, 2026
FY2025 Dec 31, 2024 $1.49B Feb 20, 2026
FY2025 Dec 31, 2023 ($831.00M) Feb 20, 2026
FY2019 Dec 31, 2018 $1.67B Mar 5, 2020
FY2013 Dec 31, 2013 $236.00M Mar 7, 2014
FY2013 Sep 30, 2013 $218.00M Mar 7, 2014
FY2013 Jun 30, 2013 $246.00M Mar 7, 2014
FY2013 Mar 31, 2013 $264.00M Mar 7, 2014
FY2013 Dec 31, 2012 $241.00M Mar 7, 2014
FY2013 Sep 30, 2012 $212.00M Mar 7, 2014

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($1.01B) Feb 20, 2026
FY2025 Dec 31, 2024 $2.05B Feb 20, 2026
FY2025 Dec 31, 2023 ($195.00M) Feb 20, 2026
FY2024 Dec 31, 2022 $2.76B Feb 20, 2025
FY2023 Dec 31, 2021 $3.11B Feb 22, 2024
FY2022 Dec 31, 2020 $2.71B Feb 23, 2023
FY2019 Dec 31, 2019 $626.00M Mar 5, 2020
FY2019 Sep 30, 2019 $748.00M Mar 5, 2020
FY2019 Jun 30, 2019 $750.00M Mar 5, 2020
FY2019 Mar 31, 2019 $760.00M Mar 5, 2020

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $456.00M Feb 20, 2026
FY2025 Dec 31, 2024 $438.00M Feb 20, 2026
FY2025 Dec 31, 2023 $478.00M Feb 20, 2026
FY2024 Dec 31, 2022 $454.00M Feb 20, 2025
FY2023 Dec 31, 2021 $354.00M Feb 22, 2024
FY2022 Dec 31, 2020 $564.00M Feb 23, 2023
FY2021 Dec 31, 2019 $659.00M Feb 24, 2022
FY2020 Dec 31, 2018 $799.00M Mar 3, 2021
FY2019 Dec 31, 2017 $925.00M Mar 5, 2020
FY2018 Dec 31, 2016 $1.02B Mar 22, 2019

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.76B Feb 20, 2026
FY2025 Dec 31, 2024 $2.19B Feb 20, 2026
FY2025 Dec 31, 2023 $2.39B Feb 20, 2026
FY2024 Dec 31, 2022 $2.63B Feb 20, 2025
FY2023 Dec 31, 2021 $3.03B Feb 22, 2024
FY2022 Dec 31, 2020 $3.07B Feb 23, 2023
FY2021 Dec 31, 2019 $3.33B Feb 24, 2022
FY2020 Dec 31, 2018 $3.79B Mar 3, 2021
FY2019 Dec 31, 2017 $2.44B Mar 5, 2020
FY2018 Dec 31, 2016 $2.65B Mar 22, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $15.82B Feb 20, 2026
FY2025 Dec 31, 2024 $17.36B Feb 20, 2026
FY2024 Dec 31, 2023 $16.34B Feb 20, 2025
FY2023 Dec 31, 2022 $18.96B Feb 22, 2024
FY2022 Dec 31, 2021 $18.37B Feb 23, 2023
FY2021 Dec 31, 2020 $18.66B Feb 24, 2022
FY2020 Dec 31, 2019 $21.00B Mar 3, 2021
FY2019 Dec 31, 2018 $20.58B Mar 5, 2020
FY2018 Dec 31, 2017 $20.87B Mar 22, 2019
FY2017 Dec 31, 2016 $21.15B Mar 12, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $10.92B Feb 20, 2026
FY2025 Dec 31, 2024 $12.24B Feb 20, 2026
FY2025 Dec 31, 2023 $10.76B Feb 20, 2026
FY2024 Dec 31, 2022 $13.57B Feb 20, 2025
FY2023 Dec 31, 2021 $11.65B Feb 22, 2024
FY2022 Dec 31, 2020 $10.10B Feb 23, 2023
FY2021 Dec 31, 2019 $10.12B Feb 24, 2022
FY2020 Dec 31, 2018 $9.87B Mar 3, 2021
FY2019 Dec 31, 2017 $9.34B Mar 5, 2020
FY2018 Dec 31, 2016 $8.69B Mar 22, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.64B Feb 20, 2026
FY2025 Dec 31, 2024 $6.96B Feb 20, 2026
FY2025 Dec 31, 2023 $6.96B Feb 20, 2026
FY2024 Dec 31, 2022 $9.36B Feb 20, 2025
FY2023 Dec 31, 2021 $9.36B Feb 22, 2024
FY2021 Dec 31, 2020 $9.36B Feb 24, 2022
FY2020 Dec 31, 2019 $9.36B Mar 3, 2021
FY2019 Dec 31, 2018 $9.36B Mar 5, 2020
FY2018 Dec 31, 2017 $9.36B Mar 22, 2019
FY2017 Dec 31, 2016 $9.35B Mar 12, 2018

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $866.00M Feb 20, 2026
FY2025 Dec 31, 2024 $2.19B Feb 20, 2026
FY2024 Dec 31, 2023 $706.00M Feb 20, 2025
FY2023 Dec 31, 2022 $3.52B Feb 22, 2024
FY2022 Dec 31, 2021 $1.59B Feb 23, 2023
FY2021 Dec 31, 2020 $48.00M Feb 24, 2022
FY2020 Dec 31, 2019 $67.00M Mar 3, 2021
FY2019 Dec 31, 2018 ($182.00M) Mar 5, 2020
FY2018 Dec 31, 2017 ($713.00M) Mar 22, 2019
FY2017 Dec 31, 2016 ($1.36B) Mar 12, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $39.00M Feb 20, 2026
FY2025 Dec 31, 2024 $26.00M Feb 20, 2026
FY2025 Dec 31, 2023 $10.00M Feb 20, 2026
FY2024 Dec 31, 2022 $8.00M Feb 20, 2025
FY2023 Dec 31, 2021 $2.00M Feb 22, 2024
FY2022 Dec 31, 2020 $14.00M Feb 23, 2023
FY2021 Dec 31, 2019 $2.00M Feb 24, 2022
FY2020 Dec 31, 2018 $5.00M Mar 3, 2021
FY2019 Dec 31, 2017 $1.00M Mar 5, 2020
FY2018 Dec 31, 2016 $5.00M Mar 22, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2021 Dec 31, 2021 $2.16B Feb 24, 2022
FY2021 Dec 31, 2020 $3.33B Feb 24, 2022
FY2020 Dec 31, 2019 $5.95B Mar 3, 2021
FY2012 Dec 31, 2012 $7.50B Mar 12, 2013

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 20, 2026
FY2025 Dec 31, 2024 1 Feb 20, 2026
FY2024 Dec 31, 2023 1 Feb 20, 2025
FY2023 Dec 31, 2022 1 Feb 22, 2024
FY2022 Dec 31, 2021 1 Feb 23, 2023
FY2021 Dec 31, 2020 1 Feb 24, 2022
FY2020 Dec 31, 2019 1 Mar 3, 2021
FY2019 Dec 31, 2018 1 Mar 5, 2020
FY2018 Dec 31, 2017 1 Mar 22, 2019
FY2017 Dec 31, 2016 1 Mar 12, 2018